Nykode Therapeutics Announces FDA Approval of IND for VB-C-0

FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20. OSLO, Norway, Sept. 05, 2023 (GLOBE NEWSWIRE)

Related Keywords

Norway , Oslo , Michael Engsig , Nykode Vaccibody , Agnete Fredriksen , Genentech , Oslo Stock Exchange , Roche Group , New York , Capital Markets Day , Antigen Presenting Cells , Nykode Therapeutics , Business Officer ,